Learning 2 Sleep L2S AB (publ)

OM:L2S Stock Report

Market Cap: SEK 10.6m

Learning 2 Sleep L2S Past Earnings Performance

Past criteria checks 0/6

Learning 2 Sleep L2S's earnings have been declining at an average annual rate of -30.2%, while the Healthcare industry saw earnings growing at 8.1% annually. Revenues have been growing at an average rate of 18% per year.

Key information

-30.2%

Earnings growth rate

95.5%

EPS growth rate

Healthcare Industry Growth8.1%
Revenue growth rate18.0%
Return on equity-95.6%
Net Margin-931.1%
Last Earnings Update30 Sep 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Learning 2 Sleep L2S makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OM:L2S Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 233-2700
30 Jun 233-1900
31 Mar 234-1800
31 Dec 225-2000
30 Jun 227-2000
31 Mar 227-1800
31 Dec 217-1600
31 Dec 205-500
31 Dec 191-500
31 Dec 180-400

Quality Earnings: L2S is currently unprofitable.

Growing Profit Margin: L2S is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: L2S is unprofitable, and losses have increased over the past 5 years at a rate of 30.2% per year.

Accelerating Growth: Unable to compare L2S's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: L2S is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (10.8%).


Return on Equity

High ROE: L2S has a negative Return on Equity (-95.57%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies